2002年5月
[Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
Gan to kagaku ryoho. Cancer & chemotherapy
- 巻
- 29
- 号
- 5
- 開始ページ
- 751
- 終了ページ
- 6
- 記述言語
- 日本語
- 掲載種別
- 研究論文(学術雑誌)
Eighteen elderly patients aged 76 years or older with small cell lung cancer were treated with carboplatin (AUC = 4 mg/ml.min, i.v. day 1) and etoposide (70 mg/m2 i.v. day 1-3) and 17 patients were evaluable. The median age of the study population was 77 years (range: 76-81). Eight patients had limited disease (LD) and nine did extensive disease (ED). The overall response rate was 88% for LD patients and 67% for ED patients. Median survival time was 219 days for LD patients and 158 days for ED patients. Grade 3 and 4 leukopenia, neutropenia, thrombocytopenia and anemia occurred in 41%, 76%, 24% and 6% of patients, respectively. There was one treatment-related death due to pneumonitis.
- リンク情報
- ID情報
-
- ISSN : 0385-0684
- PubMed ID : 12040679